LINEUB

Linear ubiquitin chains - novel cellular signals involved in inflammation and cancer

 Coordinatore JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Germany [DE]
 Totale costo 2˙440˙560 €
 EC contributo 2˙440˙560 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2009-AdG
 Funding Scheme ERC-AG
 Anno di inizio 2010
 Periodo (anno-mese-giorno) 2010-06-01   -   2015-05-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN

 Organization address address: GRUNEBURGPLATZ 1
city: FRANKFURT AM MAIN
postcode: 60323

contact info
Titolo: Ms.
Nome: Kristina
Cognome: Wege
Email: send email
Telefono: +49 69 798 15198
Fax: +49 69 798 15007

DE (FRANKFURT AM MAIN) hostInstitution 2˙440˙560.00
2    JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT AM MAIN

 Organization address address: GRUNEBURGPLATZ 1
city: FRANKFURT AM MAIN
postcode: 60323

contact info
Titolo: Prof.
Nome: Ivan
Cognome: Dikic
Email: send email
Telefono: -11973
Fax: -11898

DE (FRANKFURT AM MAIN) hostInstitution 2˙440˙560.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

autophagy    modification    chains    inflammatory    linear    nf    ub    proteins    disease    cellular    repair    ubiquitination    pathway    regulation    apoptosis    ordm    dna    cancer    ubiquitin   

 Obiettivo del progetto (Objective)

'Ubiquitin (Ub) is a small modifier that labels proteins in a highly specific manner. Like phosphorylation, modification of proteins by Ub is prevalent in the majority of cellular processes. An increasing number of distinct functions have been assigned to different types of ubiquitin modifications (monoUb and different Lys-linked chains). Moreover, aberrations in the ubiquitin system underlie many disease states, including cancer, inflammatory, immune and metabolic disorders as well as neurodegeneration. The most recently described physiological ubiquitin modification is the linear ubiquitin chain, in which ubiquitin monomers are conjugated via Met-Gly linkages. We have found that linear ubiquitin chains bind specifically to the NEMO adaptor molecule, an event critical for the proper regulation of NF-ºB signaling (Rahighi, 2009). Here we propose to use a multidisciplinary strategy to study the role of linear ubiquitination in the NF-ºB pathway, autophagy, apoptosis and DNA repair and how these changes can impact on disease states such as inflammation and cancer development. Scientific objectives are: " Characterize the components of linear ubiquitination: E3 ligases, specific substrates and domains recognizing linear ubiquitin chains " Elucidate the in vivo role of linear ubiquitination in the regulation of the NF-ºB pathway, apoptosis and DNA repair. " Reveal the molecular basis for the connections between linear ubiquitination and selective autophagy " Identify elements in the linear ubiquitin network as potential drug targets " Generate transgenic mouse models of inflammatory diseases and cancer " Develop system and computational biology approaches to assess the global role of linear ubiquitination in cellular proteome'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

SPIN (2014)

Symmetry Principles in Nature

Read More  

BIOQ (2013)

Diamond Quantum Devices and Biology

Read More  

4C (2008)

4C technology: uncovering the multi-dimensional structure of the genome

Read More